Physician
Ojugbele, Olutosin
Ojugbele, Olutosin was paid $216K by Medicaid between Jan 2021 and Nov 2024, across 13 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 49% of everything it billed.
33Billing provider infoOJUGBELE, OLUTOSIN
PROVIDENCE, RI 02903
PROVIDENCE, RI 02903
33aNPI1154741643assigned 04/23/2014
33bProvider typePediatrics Physician
28Total paid$216K
24GClaims2,455
24DCodes billed13
24AFirst – last monthJan 2021 – Nov 2024
Compared with peers
Next to other Pediatrics Physician providers in Rhode Island
Rank by total paid#90 of 265
Median peer was paid$133K
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 834 | $70K | |
| 2022 | 1,005 | $92K | |
| 2023 | 347 | $29K | |
| 2024incomplete | 269 | $25K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 49% | 1,136 | 1,096 | $105K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 12% | 426 | 413 | $27K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.9% | 161 | 157 | $21K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.8% | 130 | 128 | $17K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 7.8% | 134 | 134 | $17K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.3% | 53 | 51 | $7K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.3% | 58 | 55 | $7K |
| 90461 | 2.3% | 88 | 87 | $5K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.0% | 144 | 141 | $4K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.4% | 87 | 87 | $3K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 12 | 12 | $2K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 12 | 12 | $496.85 |
1 more codes
| 83655 | <1% | 14 | $212.71 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.